GGrantIndex
← Leaderboards

Kevin Peter Williams

North Carolina Central University

$5,886,435
Attributed
$9,003,856
Total exposure
16
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,183,485 · 18

By mechanism

R01$4,660,212 · 2
P20$2,779,040 · 4
U54$1,980,260 · 7
R15$1,182,735 · 3
SC2$291,304 · 1
R41$289,934 · 1

Top collaborators

Others in their field

Top investigators on “Innovation

Research focus

InnovationPathway InteractionsMolecularCellsMalignant NeoplasmsGenesTumorGeneticProgramsCancer Health DisparitySignal TransductionCancer PatientResearch PersonnelBiologicalAfrican AmericanWomanResearch Project GrantsCell LineUnited States National Institutes Of HealthCollaborationsInflammatory Breast CancerIn VivoFacultyBase

Grant awards (46)

Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity$666,881
R01 · FY2025 · MD
Cellular Mechanisms in Fetal Alcohol Spectrum Disorders$625,123
R01 · FY2025 · AA
Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities$241,807
U54 · FY2025 · MD · contact PI
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD)$195,075
U54 · FY2025 · AA · contact PI
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder$27,436
U54 · FY2025 · AA · contact PI
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity$666,210
R01 · FY2024 · MD
Cellular Mechanisms in Fetal Alcohol Spectrum Disorders$643,197
R01 · FY2024 · AA
Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities$235,101
U54 · FY2024 · MD · contact PI
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD)$191,248
U54 · FY2024 · AA · contact PI
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder$27,436
U54 · FY2024 · AA · contact PI
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity$677,548
R01 · FY2023 · MD
Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities$248,511
U54 · FY2023 · MD · contact PI
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD)$187,500
U54 · FY2023 · AA · contact PI
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder$27,436
U54 · FY2023 · AA · contact PI
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity$679,079
R01 · FY2022 · MD
Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities$255,216
U54 · FY2022 · MD · contact PI
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD)$186,458
U54 · FY2022 · AA · contact PI
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder$27,436
U54 · FY2022 · AA · contact PI
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity$702,174
R01 · FY2021 · MD
Engineering novel methods to study metastases and reduce systemic treatment toxicity in breast cancer patients$444,000
R15 · FY2019 · CA · contact PI
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$241,360
P20 · FY2019 · CA
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$214,449
P20 · FY2019 · CA · contact PI
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$101,565
P20 · FY2019 · CA
Project 2: Identifying and modulating genetic modifiers of GLI1 activation in inflammatory breast cancer.$81,050
P20 · FY2019 · CA · contact PI
Investigation of the role of X-Linked Inhibitor of Apoptosis Protein in African American IBC-derived$68,947
P20 · FY2019 · CA
1/2 The North Carolina Central University (NCCU)-Duke Cancer Institute (DCI) Cancer Disparities Translational Research Partnership (NCCU-DCICDTRP)$67,129
P20 · FY2019 · CA · contact PI
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$278,348
P20 · FY2018 · CA
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$190,920
P20 · FY2018 · CA · contact PI
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$104,165
P20 · FY2018 · CA
Project 2: Identifying and modulating genetic modifiers of GLI1 activation in inflammatory breast cancer.$68,685
P20 · FY2018 · CA · contact PI
1/2 The North Carolina Central University (NCCU)-Duke Cancer Institute (DCI) Cancer Disparities Translational Research Partnership (NCCU-DCICDTRP)$57,325
P20 · FY2018 · CA · contact PI
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$255,626
P20 · FY2017 · CA
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$229,982
P20 · FY2017 · CA · contact PI
Project 2: Identifying and modulating genetic modifiers of GLI1 activation in inflammatory breast cancer.$85,920
P20 · FY2017 · CA · contact PI
1/2 The North Carolina Central University (NCCU)-Duke Cancer Institute (DCI) Cancer Disparities Translational Research Partnership (NCCU-DCICDTRP)$68,786
P20 · FY2017 · CA · contact PI
Targeting DYRK1A Modulation of GLI1 for Anti-Tumor Efficacy$375,830
R15 · FY2016 · CA · contact PI
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$259,367
P20 · FY2016 · CA
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership$234,900
P20 · FY2016 · CA · contact PI
Project 2: Identifying and modulating genetic modifiers of GLI1 activation in inflammatory breast cancer.$99,027
P20 · FY2016 · CA · contact PI
1/2 The North Carolina Central University (NCCU)-Duke Cancer Institute (DCI) Cancer Disparities Translational Research Partnership (NCCU-DCICDTRP)$71,489
P20 · FY2016 · CA · contact PI
Identifying genetic modifiers of alcohol induced birth defects$129,600
U54 · FY2015 · AA · contact PI
Identification of potent and selective GLI1 inhibitors$289,934
R41 · FY2013 · CA · contact PI
Identification of Specific Antagonists that Bind Hedgehog and Block its Activity$362,905
R15 · FY2011 · CA · contact PI
The Hedgehog Pathway and Inflammatory Breast Cancer$97,102
SC2 · FY2010 · CA · contact PI
The Hedgehog Pathway and Inflammatory Breast Cancer$97,102
SC2 · FY2009 · CA · contact PI
The Hedgehog Pathway and Inflammatory Breast Cancer$97,100
SC2 · FY2008 · CA · contact PI